EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Combined Pulmonary Fibrosis and Emphysema: When Scylla and Charybdis Ally

Marija Gredic iD, Srikanth Karnati iD, Clemens Ruppert iD, Andreas Guenther, Sergey N Avdeev iD, Djuro Kosanovic

Cells · 28.04.2023 · 12 (9) · 1278

DOI: 10.3390/cells12091278 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 28.04.2023. Verfasst von Marija Gredic und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cardio-Pulmonary Institute (CPI), Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Justu…. Hauptthemen laut MEDLINE: Pulmonary Fibrosis, Pulmonary Emphysema, Hypertension, Pulmonary, Emphysema. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 197 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Combined pulmonary fibrosis and emphysema (CPFE) is a recently recognized syndrome that, as its name indicates, involves the existence of both interstitial lung fibrosis and emphysema in one individual, and is often accompanied by pulmonary hypertension. This debilitating, progressive condition is most often encountered in males with an extensive smoking history, and is presented by dyspnea, preserved lung volumes, and contrastingly impaired gas exchange capacity. The diagnosis of the disease is based on computed tomography imaging, demonstrating the coexistence of emphysema and interstitial fibrosis in the lungs, which might be of various types and extents, in different areas of the lung and several relative positions to each other. CPFE bears high mortality and to date, specific and efficient treatment options do not exist. In this review, we will summarize current knowledge about the clinical attributes and manifestations of CPFE. Moreover, we will focus on pathophysiological and pathohistological lung phenomena and suspected etiological factors of this disease. Finally, since there is a paucity of preclinical research performed for this particular lung pathology, we will review existing animal studies and provide suggestions for the development of additional in vivo models of CPFE syndrome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary FibrosisPulmonary EmphysemaHypertension, PulmonaryEmphysemaMaleHumansLung

Stichwörter der Autor:innen

CPFEanimal modelsemphysemalung fibrosis

Autor:innen und Institutionen

  • Cardio-Pulmonary Institute (CPI), Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Justus Liebig University, 35392 Giessen, Germany.
  • Institute for Anatomy and Cell Biology, Julius-Maximilians-University Würzburg, 97070 Würzburg, Germany.
  • UGMLC Giessen Biobank & European IPF Registry/Biobank, 35392 Giessen, Germany.
  • Institute for Lung Health (ILH), 35392 Giessen, Germany.
  • Lung Clinic, Evangelisches Krankenhaus Mittelhessen, 35398 Giessen, Germany.
  • Department of Pulmonology, I.M. Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia.

ORCID-Profile: Marija Gredic, Srikanth Karnati, Clemens Ruppert, Sergey N Avdeev

Zitieren

APA

Gredic, M., Karnati, S., Ruppert, C., Guenther, A., Avdeev, S. N., & Kosanovic, D. (2023). Combined Pulmonary Fibrosis and Emphysema: When Scylla and Charybdis Ally. Cells, 12(9), 1278. https://doi.org/10.3390/cells12091278

Vancouver

Gredic M, Karnati S, Ruppert C, Guenther A, Avdeev SN, Kosanovic D. Combined Pulmonary Fibrosis and Emphysema: When Scylla and Charybdis Ally. Cells. 2023;12(9):1278. doi:10.3390/cells12091278

BibTeX
@article{Gredic2023,
  author = {Gredic, Marija and Karnati, Srikanth and Ruppert, Clemens and Guenther, Andreas and Avdeev, Sergey N and Kosanovic, Djuro},
  title = {Combined Pulmonary Fibrosis and Emphysema: When Scylla and Charybdis Ally},
  journal = {Cells},
  year = {2023},
  volume = {12},
  number = {9},
  pages = {1278},
  doi = {10.3390/cells12091278}
}
Kostenlos starten →